The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation.
Camelia A Danilov; Krish Chandrasekaran; Jennifer Racz; Lucian Soane; Carol Zielke; Gary Fiskum (Profiled Author: Gary M Fiskum)
Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Oxidative stress is an important molecular mechanism of astrocyte injury and death following ischemia/reperfusion and may be an effective target of intervention. One therapeutic strategy for detoxifying the many different reactive oxygen and nitrogen species that are produced under these conditions is induction of the Phase II gene response by the use of chemicals or conditions that promote the translocation of the transcriptional activating factor NRF2 from the cytosol to the nucleus, where it binds to genomic antioxidant response elements. This study tested the hypothesis that pre- or post-treatment of cultured cortical astrocytes with sulforaphane, an alkylating agent known to activate the NRF2 pathway of gene expression protects against death of astrocytes caused by transient exposure to O(2) and glucose deprivation (OGD). Rat cortical astrocytes were exposed to 5 muM sulforaphane either 48 h prior to, or for 48 h after a 4-h period of OGD. Both pre- and post-treatments significantly reduced cell death at 48 h after OGD. Immunostaining for 8-hydroxy-2-deoxyguanosine, a marker of DNA/RNA oxidation, was reduced at 4 h reoxygenation with sulforaphane pretreatment. Sulforaphane exposure was followed by an increase in cellular and nuclear NRF2 immunoreactivity. Moreover, sulforaphane also increased the mRNA, protein level, and enzyme activity of NAD(P)H/Quinone Oxidoreductase1, a known target of NRF2 transcriptional activation. We conclude that sulforaphane stimulates the NRF2 pathway of antioxidant gene expression in astrocytes and protects them from cell death in an in vitro model of ischemia/reperfusion.
3 Originating Grant
Zielke, H Ronald
1 May 1997 - 31 January 2009
NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
MCKENNA, MARY C
1 May 1997 - 31 January 2014
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT
1 May 1995 - 31 December 2008
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Aubrey Siebert; Vandan Desai; Krish Chandrasekaran; Gary Fiskum; M Samir JafriJournal of neuroscience research 2009;87(7):1659-69.
Lucian Soane; Wei Li Dai; Gary Fiskum; Linda L BambrickJournal of neuroscience research 2010;88(6):1355-63.
Amitava Das; Labanyamoy Kole; Lihua Wang; Roberto Barrios; Bhagavatula Moorthy; Anil K JaiswalFree radical biology & medicine 2006;40(10):1843-56.
Appears in this Publication
Author of this Publication